George F. Tidmarsh - 04 Feb 2022 Form 4/A - Amendment Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director, 10%+ Owner
Signature
/s/ J.P. Galda, as attorney-in-fact for George F Tidmarsh
Issuer symbol
REVB
Transactions as of
04 Feb 2022
Net transactions value
+$132,936
Form type
4/A - Amendment
Filing time
09 Feb 2022, 15:24:52 UTC
Date Of Original Report
08 Feb 2022
Previous filing
20 Jan 2022
Next filing
10 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Purchase $18,256 +7,900 +0.54% $2.31 1,481,235 04 Feb 2022 By Trust F1
transaction REVB Common Stock Purchase $109,780 +42,100 +2.8% $2.61 1,523,335 07 Feb 2022 By Trust F1, F2
transaction REVB Common Stock Purchase $4,900 +2,000 +0.48% $2.45 416,156 04 Feb 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.
F2 Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 The original Form 4, filed on February 8, 2022, is being amended by this Form 4 amendment to include shares purchased directly that were inadvertently omitted in the original filing.